NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

The U.S. Food and Drug Administration has authorized Chapel Hill-based Cessation Therapeutics to begin a clinical trial on CSX-1004. The monoclonal antibody is designed to prevent fentanyl overdoses. The FDA’s action paves the way for the company to conduct its first clinical trials on humans. 

The mood was upbeat as North Carolina Department of Commerce Secretary Machelle Baker Sanders opened the state’s First in Talent Townhall on July 27, just two weeks after CNBC named the Tar Heel State the country’s top state for business—for the second year in a row. Sanders also serves on the North Carolina Biotechnology Center’s Board of Directors. 

BioSkryb Genomics, a Durham developer of amplification tools for single-cell analysis, has signed an agreement with a Dutch company to expand distribution of BioSkryb’s genomic and multiomic technology in Europe.BioSkryb logo

At the age of 17, Jakobi Blue-Smith of Raleigh, NC, already had an idea what she wanted to study in college. After she told her internship counselor at Wake Young Women’s Leadership Academy about her interests, it wasn’t long before she applied for an internship through OpenDoors Summer Internship (ODSI) program.

“I told my counselor the field I was interested in was biotechnology incorporated with research, and she found exactly what I was looking for,” said Blue-Smith. “I immediately applied for it.”

Kincell Bio, a new company formed to develop and manufacture cell therapies for biotechnology companies, may be based in Florida, but it has North Carolina fingerprints all over it. 

Kincell, a contract development and manufacturing organization (CDMO), was spun out of Inceptor Bio of Morrisville and has raised $36 million in Series A venture capital led by Raleigh-based Kineticos Ventures

A combination of economic development projects in multiple sectors – life sciences, electric vehicles, semiconductors, and even retail – helped land North Carolina the sole top spot in the latest issue of Area Development, a quarterly publication covering site selection, facility planning and economic development.

For the second consecutive year, North Carolina has been named by CNBC as “America’s Top State for Business.” 

“At a time when companies are clamoring for workers while trying to navigate a treacherous economy, no state is meeting their needs more effectively than North Carolina,” writes CNBC Special Correspondent Scott Cohn, who created the business news network’s annual competitiveness study of states in 2007.

“Business and the economy in the state have been on a tear since the pandemic, and the state has scarcely looked back,” he adds.

This week leaders in the life sciences are gathering in Raleigh for US Biostimulants Summit 2023. The event will concentrate on the biostimulant industry’s focus on increasing crop yields and protecting plant growth.

The small team at Raleigh-based startup, Collaborations Pharmaceuticals, spends the bulk of its time looking for safe and effective molecules that can be developed into drugs to treat rare and infectious diseases.

Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, has raised an additional $4.5 million in funding from investors.Opus Genetics logo

Cereius, Inc., a biotechnology company developing therapies to treat cancer that has spread to the brain, has been acquired by San Diego-based Solve Therapeutics, Inc. (SolveTx).

WINSTON-SALEM - Salem Academy and College has placed a high priority on STEM education in recent years, helping more women and girls develop and deploy their skills in science, technology, engineering and mathematics. 

So it’s only fitting that NASA - sitting at the forefront of science and technology - has taken notice. The space agency has awarded Salem Academy and College a three-year grant worth nearly $750,000 to attract and retain women in STEM degree programs and careers. 

Medical device startup restor3d, which uses 3D printing for a more individualized approach to implant surgery, is getting bigger.

The Durham-headquartered company has entered into a definitive merger agreement with Conformis, Inc. to acquire all outstanding shares of common stock of the Massachusetts-based business for $2.27 per share. The all-cash deal is a 96% premium to Conformis’ closing price on June 22. It should be completed by the end of the third quarter of this year.

KaryoLogic, a karyotyping services company based in Durham, is teaming up with a French biotechnology company to test and analyze chromosomes in human stem cells.

The partnership with Stem Genomics of Montpellier, France, will allow KaryoLogic to offer a digital assay that can identify more than 90% of the most common genomic abnormalities found in human pluripotent stem cells, according to KaryoLogic.

Back in 2018, walking away from a conversation with North Pitt High School sophomore Diana De Leon, Mark Phillips knew he wanted to help her. He just needed to figure out how. 

Mark is North Carolina Biotechnology Center’s Vice President of Statewide Operations and Executive Director of its Eastern Regional Office in the public power city of Greenville, North Carolina. 

scroll back to top of page